Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Stephen Shulman, M.D.

Co-Author

This page shows the publications co-authored by David Shulman and Dylan Neel.
Connection Strength

0.476
  1. Sponsorship of oncology clinical trials in the United States according to age of eligibility. Cancer Med. 2020 07; 9(13):4495-4500.
    View in: PubMed
    Score: 0.218
  2. Timing of first-in-child trials of FDA-approved oncology drugs. Eur J Cancer. 2019 05; 112:49-56.
    View in: PubMed
    Score: 0.202
  3. Landscape of phase 1 clinical trials for minors with cancer in the United States. Pediatr Blood Cancer. 2020 11; 67(11):e28694.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.